Article info
Ovarian Cancer
Survivin Expression as a Prognostic Factor in Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer Treated With Neoadjuvant Chemotherapy
- Address correspondence and reprint requests to Lubomir Bodnar, PhD, MD, Department of Oncology, Military Institute of Medicine, 04-141 Warsaw, 128 Szaserow Str, Poland. E-mail: lubo{at}esculap.p.
Citation
Survivin Expression as a Prognostic Factor in Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer Treated With Neoadjuvant Chemotherapy
Publication history
- Received November 17, 2013
- Accepted January 14, 2014
- First published May 1, 2014.
Online issue publication
June 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2014 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.